Browsing by Author "Fabbri, Leonardo M"
Now showing 1 - 9 of 9
- Results Per Page
- Sort Options
Item Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients(2022-12-22) Price, David; Henley, William; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Papi, Alberto; Fabbri, Leonardo M; Kerstjens, Huib AM; Roche, Nicolas; Singh, Dave; Vogelmeier, Claus F; Şen, Elif; Delfini Cançado, José Eduardo; Kots, Maxim; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients(2022-12-01) Price, David; Henley, William; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Papi, Alberto; Fabbri, Leonardo M; Kerstjens, Huib AM; Roche, Nicolas; Singh, Dave; Vogelmeier, Claus F; Şen, Elif; Delfini Cançado, José Eduardo; Kots, Maxim; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Comparative effectiveness of triple therapy versus dual bronchodilation in COPD(2019-08-30) Voorham, Jaco; Corradi, Massimo; Papi, Alberto; Vogelmeier, Claus F; Singh, Dave; Fabbri, Leonardo M; Kerkhof, Marjan; Kocks, Janwillem H; Carter, Victoria; Price, David; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health SciencesItem Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone(2021-09-05) Price, David; Henley, William; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Papi, Alberto; Fabbri, Leonardo M; Kerstjens, Huib AM; Roche, Nicolas; Singh, Dave; Vogelmeier, Claus F; Şen, Elif; Delfini Cançado, José Eduardo; Nudo, Elena; Barile, Sara; Georges, GeorgeItem Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD(2024-03-26) Singh, Dave; Price, David; Henley, William; Delfini Cançado, José Eduardo; Fabbri, Leonardo M; Kerstjens, Huib AM; Papi, Alberto; Roche, Nicolas; Şen, Elif; Vogelmeier, Claus F; Nudo, Elena; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Soriano, Joan B; Kots, Maxim; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone(2022-02-15) Price, David; Henley, William; Delfini Cançado, José Eduardo; Fabbri, Leonardo M; Kerstjens, Huib AM; Papi, Alberto; Roche, Nicolas; Şen, Elif; Singh, Dave; Vogelmeier, Claus; Barille, Sara; Nudo, Elena; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone(2022-03) Price, David; Henley, William; Carter, Victoria; Skinner, D; Vella, Rebecca; Papi, A.; Fabbri, Leonardo M; Kertsjens, H; Roche, N; Singh, D; Vogelmeier, C; Sen, E; Cancado, J; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)(2021-09-05) Price, David; Henley, William; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Papi, Alberto; Fabbri, Leonardo M; Kerstjens, Huib AM; Roche, Nicolas; Singh, Dave; Vogelmeier, Claus F; Şen, Elif; Delfini Cançado, José Eduardo; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS(2024-01-20) Price, David; Henley, William; Delfini Cançado, José Eduardo; Fabbri, Leonardo M; Kerstjens, Huib AM; Papi, Alberto; Roche, Nicolas; Şen, Elif; Singh, Dave; Vogelmeier, Claus F; Nudo, Elena; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Soriano, Joan B; Kots, Maxim; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health Sciences